Trending
- Woman who has endured three cancers completes 141-hill challenge
- Boy whose cancer returned two weeks after remission gets new hope from trial
- CFTR-driven immune microenvironment reprogramming synergizes with anti-PD-L1 antibody in hepatocellular carcinoma
- 74 Real-World Study Characterizing Patient Characteristics, Treatments, and Unmet Need in IO-Ineligible Patients With Metastatic Triple-Negative Breast Cancer
- Is Any Alcohol Good for You? Health Risks of Alcohol| U.S. News
- Tisa-Cel Yields Enduring Remissions in Younger High-Risk B-ALL Population
- Fixed-Duration Epcoritamab Combo Shows Superiority in Follicular Lymphoma
- Blood Cancer United buys drug stockpile for compassionate use
